4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0001209191-17-022934
Director bought 25,000 shares at $2.59 ($64,750)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| CONWAY ROBERT E Director | 2017-03-24 | Purchase | +25,000 | $2.59 | $64,750 | 25,000 | D |
| Open-market purchases · 25,000 sh · avg $2.59 · $64,750 | |||||||
Loading xslF345X03/doc4.xml…